A comparative study of doxazosin versus atenolol in mild-to-moderate hypertension
- 31 December 1988
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 116 (6), 1801-1805
- https://doi.org/10.1016/0002-8703(88)90233-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertensionThe American Journal of Cardiology, 1987
- Efficacy and safety of doxazosin in hypertension therapyThe American Journal of Cardiology, 1987
- Mechanism of alpha blockade for blood pressure controlThe American Journal of Cardiology, 1987
- Clinical pharmacology of doxazosin in patients with essential hypertensionClinical Pharmacology & Therapeutics, 1987
- The antihypertensive effects of doxazosin: a clinical overview.British Journal of Clinical Pharmacology, 1986
- Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.British Journal of Clinical Pharmacology, 1986
- Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.British Journal of Clinical Pharmacology, 1986
- The alpha 1‐adrenoceptor antagonist profile of doxazosin: preclinical pharmacology.British Journal of Clinical Pharmacology, 1986
- A Comparative Study Between 100mg Atenolol and 20mg Pindolol Slow-Release in Essential HypertensionDrugs, 1983
- Ambulatory Blood Pressure and its Variability During Randomised Double-blind Administration of Atenolol, Metoprolol, Pindolol and Long Acting Propranolol in Subjects with Mild to Moderate HypertensionDrugs, 1983